Abstract:Understanding mechanisms of ageing remains a complex challenge for biogerontologists, but recent adaptations of evolutionary ageing theories offer a compelling lens in which to view both age-related molecular and physiological deterioration. Ageing is commonly associated with progressive declines in biochemical and molecular processes resulting from damage accumulation, yet the role of continued developmental gene activation is less appreciated. Natural selection pressures are at their highest in youthful periods to modify gene expression towards maximising reproductive capacity. After sexual maturation, selective pressure diminishes, subjecting individuals to maladaptive pleiotropic gene functions that were once beneficial for developmental growth but become pathogenic later in life. Due to this selective 'shadowing' in ageing, mechanisms to counter such hyper/hypofunctional genes are unlikely to evolve. Interventions aimed at targeting gene hyper/hypofunction during ageing might, therefore, represent an attractive therapeutic strategy. The nematode Caenorhabditis elegans offers a strong model for post-reproductive mechanistic and therapeutic investigations, yet studies examining the mechanisms of, and countermeasures against, ageing decline largely intervene from larval stages onwards. Importantly, however, lifespan extending conditions frequently impair early-life fitness and fail to correspondingly increase healthspan. Here, we consolidate multiple evolutionary theories of ageing and discuss data supporting hyper/hypofunctional changes at a global molecular and functional level in C. elegans, and how classical lifespan-extension mutations alter these dynamics. The relevance of such mutant models for exploring mechanisms of ageing are discussed, highlighting that post-reproductive gene optimisation represents a more translatable approach for C. elegans research that is not constrained by evolutionary trade-offs. Where some genetic mutations in C. elegans that promote late-life health map accordingly with healthy ageing in humans, other widely used genetic mutations that extend worm lifespan are associated with life-limiting pathologies in people. Lifespan has also become the gold standard for quantifying 'ageing', but we argue that gerospan compression (i.e., 'healthier' ageing) is an appropriate goal for anti-ageing research, the mechanisms of which appear distinct from those regulating lifespan alone. There is, therefore, an evident need to re-evaluate experimental approaches to study the role of hyper/hypofunctional genes in ageing in C. elegans.

Ageing and immortality

A scenario for an evolutionary selection of ageing

Evolution of senescence: late survival sacrificed for reproduction

The Accumulation Theory of Ageing

Immortality as a physical problem

Ageing as a two-phase process: theoretical framework

Theory and associated phenomenology for intrinsic mortality arising from natural selection

How evolution makes us age: Introducing the evolvable soma theory of ageing

Directionality Theory and Mortality Patterns Across the Primate Lineage

Ageing and the goal of evolution

Evolution of ageing as a tangle of trade-offs: energy versus function

Aging in the Context of Cohort Evolution and Mortality Selection.

Universal Mortality Law, Life Expectancy and Immortality

Minireview: What Evolutionary Biology Can Do for Gerontology

Biological Restraints on Indefinite Survival

Cellular senescence, rejuvenation and potential immortality

Change and Aging Senescence as an adaptation

Consolidating multiple evolutionary theories of ageing suggests a need for new approaches to study genetic contributions to ageing decline